Since acute in vivo treatment with anandamide has been shown to decrease intraperitoneal glucose tolerance in wild type mice [34, 35] but not in CB1R-/- mice [34], there is a possibility that elevation of plasma anandamide levels may be a cause rather than consequence (compensatory signal) of insulin resistance. This evidence concerns the gene CNR1 and Insulin resistance.